RAIMONDI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 10.490
EU - Europa 10.380
AS - Asia 3.821
SA - Sud America 619
Continente sconosciuto - Info sul continente non disponibili 174
AF - Africa 134
OC - Oceania 67
Totale 25.685
Nazione #
US - Stati Uniti d'America 10.317
PL - Polonia 5.348
RU - Federazione Russa 1.815
IT - Italia 1.281
SG - Singapore 1.214
CN - Cina 764
HK - Hong Kong 668
BR - Brasile 499
IE - Irlanda 456
VN - Vietnam 454
SE - Svezia 411
KR - Corea 255
DE - Germania 242
FI - Finlandia 181
FR - Francia 171
UA - Ucraina 167
GB - Regno Unito 146
IN - India 112
CA - Canada 98
AU - Australia 67
JO - Giordania 67
ID - Indonesia 56
CH - Svizzera 50
BD - Bangladesh 47
JP - Giappone 43
TR - Turchia 37
AR - Argentina 34
ZA - Sudafrica 33
ES - Italia 30
CI - Costa d'Avorio 23
EC - Ecuador 23
IQ - Iraq 23
MX - Messico 23
NL - Olanda 22
BE - Belgio 16
CL - Cile 16
NG - Nigeria 14
CO - Colombia 13
PK - Pakistan 13
MA - Marocco 12
SC - Seychelles 12
VE - Venezuela 11
JM - Giamaica 10
CR - Costa Rica 9
PY - Paraguay 9
AT - Austria 8
EG - Egitto 8
HN - Honduras 8
KE - Kenya 8
LT - Lituania 8
PH - Filippine 8
PE - Perù 7
SA - Arabia Saudita 7
IL - Israele 6
NP - Nepal 6
TN - Tunisia 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
DZ - Algeria 5
NI - Nicaragua 5
SN - Senegal 5
GR - Grecia 4
GT - Guatemala 4
MY - Malesia 4
PR - Porto Rico 4
AZ - Azerbaigian 3
BO - Bolivia 3
DK - Danimarca 3
EU - Europa 3
KW - Kuwait 3
MU - Mauritius 3
OM - Oman 3
RS - Serbia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CG - Congo 2
ET - Etiopia 2
HU - Ungheria 2
IR - Iran 2
KZ - Kazakistan 2
MK - Macedonia 2
PA - Panama 2
PT - Portogallo 2
TW - Taiwan 2
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GP - Guadalupe 1
GY - Guiana 1
KG - Kirghizistan 1
Totale 25.506
Città #
Warsaw 5.342
Santa Clara 1.916
Ashburn 1.135
Fairfield 863
Singapore 844
Hong Kong 560
Chandler 481
Dublin 455
Woodbridge 382
Seattle 353
San Jose 351
Cambridge 317
Houston 306
Wilmington 283
Seoul 250
Jacksonville 237
Council Bluffs 228
Beijing 225
Milan 223
Buffalo 191
Ann Arbor 176
Los Angeles 160
The Dalles 140
Florence 129
Princeton 129
Altamura 128
Lawrence 127
Ho Chi Minh City 115
Lauterbourg 92
Hanoi 89
Dallas 87
Boston 75
Boardman 73
Mumbai 72
Munich 71
Rome 71
Phoenix 70
Hefei 69
Dong Ket 68
Medford 67
Moscow 64
Helsinki 63
Melbourne 61
Brunswick 60
Shanghai 56
New York 55
San Diego 55
Naples 46
Jakarta 45
São Paulo 43
Tokyo 41
Bern 40
Paris 40
Clifton 32
Chicago 29
Kent 27
London 27
Toronto 27
Falls Church 25
Bologna 24
Dearborn 24
Abidjan 23
Figino 22
Orem 21
Turku 21
Columbus 20
Brooklyn 19
Turin 19
Atlanta 18
Guangzhou 18
Da Nang 17
Haiphong 17
Norwalk 17
San Francisco 17
Hillsboro 16
Izmir 16
Brussels 15
Cape Town 15
Brasília 14
Frankfurt am Main 14
Barcelona 13
Miano 13
Montreal 13
Redondo Beach 13
Rio de Janeiro 13
Belo Horizonte 12
Johannesburg 12
Palermo 12
Tianjin 12
Auburn Hills 11
Ottawa 11
Abuja 10
Chennai 10
Denver 10
Dhaka 10
Nuremberg 10
Poplar 10
Quito 10
Siena 10
Springfield 10
Totale 18.398
Nome #
Anticonvulsant and Neuroprotective Effects of the Thyroid Hormone Metabolite 3-Iodothyroacetic Acid. 452
3-iodothyroacetic acid, a metabolite of thyroid hormone, induces itch and reduces threshold to noxious and to painful heat stimuli in mice 409
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 406
3-Iodothyroacetic acid (TA1), a by-product of thyroid hormone metabolism, reduces the hypnotic effect of ethanol without interacting at GABA-A receptors. 383
4-methyl benzylamine stimulates food consumption and counteracts the hypophagic effects of amphetamine acting on brain Shaker-like Kv1.1 channels. 376
Histamine mediates behavioural and metabolic effects of 3-iodothyroacetic acid, an endogenous end product of thyroid hormone metabolism 375
A REDUCED FUNCTIONALITY OF GI PROTEINS AS A POSSIBLE CAUSE FOR FIBROMYALGIA 372
Antioxidant protection in cultured corneal cells and whole corneas submitted to UV-B exposure. 367
Pharmacological perspectives in sarcopenia: A potential role for renin-angiotensin system blockers? 354
3-iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mouse 352
3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors. 350
The pro-healing effect of exendin-4 on wounds produced by abrasion in normoglycemic mice 346
Monoamine oxidase is over-activated in left and right ventricles from ischemic hearts: an intriguing therapeutic target. 342
Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists. 340
Antisense knockdown of the Shaker Kv1.1 gene family abolishes the central stimulatory effect of amphetamines in mice and rats. 334
Sustained Exendin-4 Secretion through Gene Therapy Targeting Salivary Glands in Two Different Rodent Models of Obesity/Type 2 Diabetes. 333
Methylamine: a new endogenous modulator of neuron firing? 332
THE REDUCTION OF FOOD INTAKE INDUCED IN MICE BY BENZYLAMINE AND ITS DERIVATIVES 322
Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats 320
In the brain of mice,3-iodothyronamine(T1AM) is converted into 3-iodothyroaceticacid(TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine 319
Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold 318
Lysosomal enzymes in experimental allergic encephalomyelitis: time course and evidence of the source. 315
Methylamine and benzylamine induced hypophagia in mice: Modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels 311
New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection. 308
Isolation and pharmacological activities of the Tecoma stans alkaloids. 307
Thyroid Hormone, Thyroid Hormone Metabolites and Mast Cells: A Less Explored Issue. 301
Selective inhibition of amine oxidases differently potentiate the hypophagic effect of benzylamine in mice. 300
3-iodothyronamine, a new chapter in thyroid story: implications in learning processes 299
oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and post-ischemic myocardial injury 296
N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity 294
Hit-to-Lead Optimization of Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists with a Diphenylmethane-Scaffold: Design, Synthesis, and Biological Study 293
Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats 291
Franca Buffoni (1924-2011): a pioneer in biochemical pharmacology 290
Amino acid sequence of mouse nidogen, a multidomain basement membrane protein with binding activity for laminin, collagen IV and cells. 288
The impact of scopolamine pretreatment on 3-iodothyronamine (T1AM) effects on memory and pain in mice. 286
Lipid peroxidation and cyclooxygenase-2 activity in human hepatocellular carcinoma cell lines with and without multiple drug resistance: correlation with cell growth 275
Angiotensin-II drives human satellite cells toward hypertrophy and myofibroblast trans-differentiation by two independent pathways 269
Losartan ameliorates diabetic vascular hyper-reactivity to angiotensin II by reducing ROCK1 expression and activity 267
The sodium-dependent glucose transporters (SGLT) as a new promising pharmacological target in human ischaemic hearts 264
Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases. 263
Metabolism of methylamine by semicarbazide-sensitive amine oxidase in white and brown adipose tissue of the rat. 261
Commentary: 3-Iodothyronamine Reduces Insulin Secretion In Vitro via a Mitochondrial Mechanism 259
The control of MAO activity, a resource underscored by the pharmacology 253
Farmaci attivi sull'omeostasi glucidica 251
Analoghi del glucagon-like peptide (GLP-1) per uso topico 251
Losartan reduces oxidative damage to renal DNA and conserves plasma antioxidant capacity in diabetic rats. 236
Activity and expression of semicarbazide-sensitive amine oxidase in a rodent model of diabetes: interactive effects with methylamine and alpha-amino guanidine 230
SODIUM-DEPENDENT GLUCOSE TRANSPORTERS (SGLT) IN HUMAN ISCHEMIC HEART: A NEW POTENTIAL PHARMACOLOGICAL TARGET 230
Apoptosis induced by sulindac sulfide in epithelial and mesenchymal cells from human abdominal neoplasms. 226
Which is the main molecular target responsible for the cardiovascular benefits in the empa-reg outcome trial? A journey through the kidney, the heart and other interesting places 223
Pharmacological applications of copper amine oxidase inhibitors 222
The effect of losartan treatment on the response of diabetic cardiomyocytes to ATP depletion 216
Exposure of cardiomyocytes to angiotensin II induces over-activation of monoamine oxidase type A: implications in heart failure 216
3-Iodothyronamine Affects Thermogenic Substrates' Mobilization in Brown Adipocytes. 216
Hydrogen peroxide generation by monoamine oxidases in rat white adipocytes: role on cAMP production 209
Reaction of pig plasma benzylamine oxidase with beta-aminopropionitrile. 202
Tisochrysis lutea F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling 201
Pharmacological inhibition of serine proteases to reduce cardiac inflammation and fibrosis in atrial fibrillation 201
Copper-dependent amine oxidases in angiogenesis induced by prostaglandin E1 (PGE1). 193
Arthrospira platensis F&M-C265 reduces cardiometabolic risk factors in rats fed a high fat diet 190
Lipid and protein oxidation products,antioxidant status and vascular complications in poorly controlled type 2 diabetes 188
Immunosuppressive activity of 13-cis-retinoic acid in rats: aspects of pharmacokinetics and pharmacodynamics. 187
Some histamine-related compounds interacting with the benzylamine oxidizing activity of rat white adipocytes. 187
Calcium modulatory properties of 2,6-dibutylbenzylamine (B25) in rat isolated vas deferens, cardiac and smooth muscle preparations. 186
Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: From molecular mechanisms to therapeutic implications 186
Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells 184
Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study 183
Activity and expression of semicarbazide-sensitive benzylamine oxidase in a rodent model of diabetes: interactive effects with methylamine and alpha-aminoguanidine. 183
Commentary: Euthyroid Sick Syndrome in Patients With COVID-19 182
Skin wound healing: some biochemical parameters in guinea-pig. 181
Methylamine-dependent release of nitric oxide and dopamine in the CNS modulates food intake in fasting rats 179
Pyridoxamine as inhibitor of the blood plasma benzylamine oxidase and other copper-containing amine oxidases. 179
Endogenous substrates of the semicarbazide-sensitive amine oxidase increased nitric oxide production in rat white adipocytes 177
Taurine prevents streptozotocin impairment of hormone-stimulated glucose uptake in rat adipocytes 176
n-3 polyunsaturated fatty acid supplementation reduces asymmetric dimethylarginine and arachidonate accumulation in spontaneously hypertensive rats 176
Benzylamine-related compounds stimulate rat was deferens neurotransmission and potentiate memory in the mouse acting as potassium potassium channel blockers. 172
Hypofunctionality of Gi proteins as aetiopathogenetic mechanism for migraine and cluster headache. 172
The protective effect of losartan in the nephropathy of the diabetic rat includes the control of monoamine oxidase type A activity. 172
null 171
Methylamine, but not ammonia, is hypophagic in mouse by interaction with brain Kv1.6 channel subtype. 170
The critical role of the proximal calcium ion in the structural properties of horseradish peroxidase 169
Chronic treatment with omega3-PUFA decreases plasma concentration of asymmetric dimethyl arginine (ADMA) in aged spontaneously hypertensive rat (SHR). 169
Asymmetric dimethyl arginine (ADMA), homocysteine and semicarbazide-sensitive amine oxidase activity (SSAO): new markers of oxidative stress in acute coronary syndromes 163
Possible different fates for the hydrogen peroxide produced by rat white adipocyte amine oxidases 162
The polysaccharide from Tamarindus indica (TS-polysaccharide) protects cultured corneal-derived cells (SIRC cells) from ultraviolet rays. 159
Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1) 159
Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. 156
DM232 and DM235, two potent cognition-enhancers, increase NO levels in rat adipocytes 150
Effect of xyloglucan Tamarind seed polysaccharide) on conjunctival cell adhesion to laminin and on corneal epithelium wound healing. 149
Monoamine oxidase is overactivated in the human left and right ventricles from ischemic hearts: an intriguing therapeutic target. 148
Amino acid sequence of mouse nidogen, a multidomain basement membrane protein with binding activity for laminin, collagen type IV and cells 147
Functional coupling of angiotensin II type 1 receptor with insulin resistance of energy substrate uptakes in immortalized cardiomyocytes (HL-1 cells). 146
SEDUM TELEPHIUM L. POLYSACCHARIDES CONTENT AFFECTS MRC% CELL ADHESION TO LAMININ AND FIBRONECTIN 145
Restoration of Cardiomyocyte Functional Properties byAngiotensin II Receptor Blockade in Diabetic Rats 145
The multiple drug resistence phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line. 145
Monoamine oxidase activity in end-stage heart failure associated with dilated and ischemic cardiomyopathies: a comparison between left and right ventricles 141
Protection against ultraviolet B-induced oxidative DNA damage in rabbit corneal-derived cells (SIRC) by 4-coumaric acid. 138
Gender-related drug effect on several markers of oxidation stress in diabetes patients with and without complications 136
Stato ossidante-antiossidante nel diabete sperimentale: ruolo del sistema AT-II 136
Monoamine oxidase in end-stage heart failure associated with dilated and ischemic cardiomyopaties: a comparison between left and right ventricles. 133
Totale 24.092
Categoria #
all - tutte 62.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.182


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022645 0 0 0 34 33 31 34 58 44 59 131 221
2022/20232.128 196 368 123 136 160 369 285 119 244 11 58 59
2023/2024720 26 81 128 38 48 85 39 136 21 29 52 37
2024/20255.553 158 538 351 796 1.684 742 115 431 239 151 188 160
2025/20265.861 578 721 526 408 723 247 749 296 378 340 163 732
2026/20271.026 173 191 539 123 0 0 0 0 0 0 0 0
Totale 25.685